2013
DOI: 10.1186/1471-2458-13-910
|View full text |Cite
|
Sign up to set email alerts
|

Early infant diagnosis of HIV in three regions in Tanzania; successes and challenges

Abstract: BackgroundBy the end of 2009 an estimated 2.5 million children worldwide were living with HIV-1, mostly as a consequence of vertical transmission, and more than 90% of these children live in sub-Saharan Africa. In 2008 the World Health Organization (WHO), recommended early initiation of Highly Active Antiretroviral Therapy (HAART) to all HIV infected infants diagnosed within the first year of life, and since 2010, within the first two years of life, irrespective of CD4 count or WHO clinical stage. The study ai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
31
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(38 citation statements)
references
References 14 publications
5
31
2
Order By: Relevance
“…In a recent study in five districts of central Malawi assessing the impact of Option B+, documentation of baseline characteristics and follow‐up parameters of HIV‐exposed infants was poor at 27%, with only 20% of infants having EID performed; and median age of testing varied from 10 to 16 weeks . Similar to our study, other recent studies from Mozambique , Nigeria , Tanzania and the Democratic Republic of the Congo have found large losses to follow‐up in HIV‐exposed infants, especially in relation to EID, where similar to the findings of our study infants also often come late for testing . Ways to reduce losses to follow‐up need to be found.…”
Section: Discussionsupporting
confidence: 89%
“…In a recent study in five districts of central Malawi assessing the impact of Option B+, documentation of baseline characteristics and follow‐up parameters of HIV‐exposed infants was poor at 27%, with only 20% of infants having EID performed; and median age of testing varied from 10 to 16 weeks . Similar to our study, other recent studies from Mozambique , Nigeria , Tanzania and the Democratic Republic of the Congo have found large losses to follow‐up in HIV‐exposed infants, especially in relation to EID, where similar to the findings of our study infants also often come late for testing . Ways to reduce losses to follow‐up need to be found.…”
Section: Discussionsupporting
confidence: 89%
“…However, EID rates are substantially below what has been estimated by other studies (Chiduo et al 2013). …”
Section: Infant Testingcontrasting
confidence: 43%
“…This figure is small as compared to the study at St. Luke hospital, Gondar University Referral hospital, and Tanzania [1719]. Infants who took PMTCT "Option B+" were all negative for HIV at 6–8 weeks while those who didn’t take any prophylaxis or those who took single dose Nevirapine had the highest infection rate.…”
Section: Discussionmentioning
confidence: 80%